Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection.
about
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virusSpecificity, cross-reactivity and function of antibodies elicited by Zika virus infectionVirus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodiesThe Cellular Bases of Antibody Responses during Dengue Virus InfectionRapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell culturesThe Complexity of a Dengue Vaccine: A Review of the Human Antibody ResponseDeconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityMapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and VaccinationDengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arbovirusesThe Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and ImmunoprophylaxisHumoral cross-reactivity between Zika and dengue viruses: implications for protection and pathologyH7N9 influenza virus neutralizing antibodies that possess few somatic mutationsRecombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.Characterization of dengue virus 2 growth in megakaryocyte-erythrocyte progenitor cells.The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope proteinIsolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.Atomic-level functional model of dengue virus Envelope protein infectivity.The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteinsDengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.Germinal center reaction following cutaneous dengue virus infection in immune-competent miceFluorescently labeled dengue viruses as probes to identify antigen-specific memory B cells by multiparametric flow cytometry.Dengue virus infection induces broadly cross-reactive human IgM antibodies that recognize intact virions in humanized BLT-NSG miceSource and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte ModelComplexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive AntibodiesSpleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes during Antibody-enhanced Dengue Virus Infection.Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.Identification of human neutralizing antibodies that bind to complex epitopes on dengue virionsDengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.Analysis of human monoclonal antibodies generated by dengue virus-specific memory B cells.Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site.Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencing.Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response.An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection.Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics.Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1.B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.Recognition of influenza H3N2 variant virus by human neutralizing antibodies.High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection.Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.
P2860
Q25161212-B7261031-018A-4542-97E9-4053504C37C8Q26252507-DAA02BAC-3104-4467-AD01-B29D66D24E01Q26314715-C93A18DF-46F7-46CC-824C-4C5195033B02Q26700056-ABC5C1DF-20F1-438D-8467-707E63CB8290Q26700070-65290A18-35AD-4FAD-8A57-10CB7E650475Q26995782-74816B1C-F967-4772-9916-218E1BA83253Q27654848-DCF3D183-568E-4C20-AD74-F5A3965EF635Q28114614-E9D6AC1C-4F5A-42FE-8D95-605221A4EE23Q28577861-EA74FC71-B3B7-43EB-9F10-BDA5BFC291BCQ28804225-67A704B9-52AB-4462-AB6B-BD353F0300FDQ29994510-8E68702F-E765-424F-84BF-2B264C330C41Q30385356-4106EFD0-6892-4EAA-AB24-88EA163C5B66Q30395028-2A728858-B4E2-4B34-8552-584CB70DEBA9Q33431345-087A997A-04B3-4858-BEAE-90724D86D31CQ34386384-14607E6F-209F-4350-8F49-559F3212DB82Q34593818-B9AEF2BB-967B-4C76-BF58-214F18445FA9Q35026063-E46FCFD6-A0F9-4731-8F1D-172DCBA2F594Q35069160-810DC186-07D2-4788-8D3B-FCBAADA4ACCCQ35138111-E5658B7E-1A25-4342-8F8A-7339911C1B05Q35294150-0E0D895F-EF73-41A7-A76D-B1218931373AQ35535146-EFB78E68-3541-40DC-A32B-02B7F3CDDE2BQ35632639-E927A19F-5058-4FDD-BED7-87605B76FD63Q35659085-5CAC6DB9-B065-4663-A711-6F708E6FCC96Q35753613-B8677843-474C-4CB5-B43A-D1A94019B1F3Q35758626-331B5880-DE04-4751-BD6C-6A9B4C81381FQ35837150-1135D8ED-6E63-447C-9F06-2BF6EC35BC0BQ35850197-664FC28E-DB2F-47CF-B109-ECB4BD9ADFE0Q35982791-CF01368A-80AB-4409-BEC4-30E3C219F2D4Q36286276-BF516B20-DA21-4929-B50E-726C0058F63AQ36305202-9FFC6688-7764-4BE4-8B19-556F4A8E701AQ36434210-29B54646-B168-4909-9EA1-AD50D8B74F5AQ36584038-8F96A0BD-5697-4165-B504-D8B90BA8BC44Q36616521-9E4EF9DB-BCA3-467E-858E-87BB71567AF9Q36667964-F95BA7F8-7778-43B8-B8B3-1DE18C856C2BQ36846290-D02EFFCF-F5C0-47FF-AE5E-18AAE4E2E52EQ36878970-31C578D2-9FBE-4BC1-9272-9BE70CB62475Q36950883-BF458B8E-6CB2-4073-8B59-12D35C4687F1Q37130531-D49A6BA2-9C09-4C75-A7B3-00C9041D5AA1Q37336440-E3E7CC0D-A7D8-4055-8F15-29712670F3C3Q37571377-5C8E32BD-DCA3-49A5-B685-8D339AE87DCC
P2860
Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Persistence of circulating mem ...... r decades following infection.
@en
type
label
Persistence of circulating mem ...... r decades following infection.
@en
prefLabel
Persistence of circulating mem ...... r decades following infection.
@en
P2093
P2860
P356
P1433
P1476
Persistence of circulating mem ...... r decades following infection.
@en
P2093
Anne H Broadwater
Nicholas P Olivarez
Scott A Smith
P2860
P304
P356
10.1128/JVI.06335-11
P407
P577
2011-12-14T00:00:00Z